Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Самоконтроль гликемии необходим для успешного лечения сахарного диабета
________________________________________________
Biriukova E.V., Askerkhanov R.G. Glycemia self-control is necessary for successful diabetes treatment. Consilium Medicum. 2018; 20 (12): 105–109. DOI: 10.26442/20751753.2018.12.000044
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Ключевые слова: сахарный диабет, хронические осложнения, сердечно-сосудистые заболевания, гипергликемия, гипогликемия, самоконтроль гликемии.
________________________________________________
Key words: diabetes mellitus, chronic complications, cardiovascular disease, hyperglycemia, hypoglycemia, glycemia self-control.
2. IDF atlas. 8th edition.
3. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, Nathan DM, Zinman B et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983–2005). Arch Intern Med 2009; 169 (14): 1307–16.
4. Farmer A, Wade A, Goyder E et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 2007; 335: 13.
5. Алгоритмы специализированной медицинской помощи больных сахарным диабетом. Под ред. И.И.Дедова, М.В.Шестаковой. 8-й вып. М., 2017. / Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nykh sakharnym diabetom. Pod red. I.I.Dedova, M.V.Shestakovoi. 8-i vyp. M., 2017. [in Russian]
6. Blonde L, Karter AJ. Current evidence regarding the value of self monitored blood glucose testing. Am J Med 2005; 118 (Suppl 9A): 20S–6S.
7. Clar C et al. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess 2010; 14 (12): 6.
8. Майоров А.Ю., Мельникова О.Г., Филиппов Ю.И. Вопросы самоконтроля гликемии в практике лечения сахарного диабета. Справочник поликлинического врача. 2012; 12: 32–6. / Maiorov A.Iu., Mel'nikova O.G., Filippov Iu.I. Voprosy samokontrolia glikemii v praktike lecheniia sakharnogo diabeta. Handbook for Practitioners Doctors. 2012; 12: 32–6. [in Russian]
9. Davidson MB, Castellanos M, Kain D et al. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med 2005; 118: 422–5.
10. Guerci B et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003; 29: 587–94.
11. Karter AJ, Ackerson LM, Darbinian JA et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med 2001; 111 (1): 1–9.
12. Polonsky WH, Fisher L, Schikman CH et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes. Results from the structured testing program study. Diabetes Care 2011; 34: 262–7.
13. Neisser K, Weber C, Wenzel H, Schneider B. Costs of self-measurement of blood glucose (SMBG) regarding morbidity and mortality in type 2 diabetes in a reality of care setting (The ROSSO study No 6). The European Association for the Study of Diabetes. Abstract Volume 42st Annual Meeting, Copenhagen, Malmoe, 2006; p. 141.
14. McGeoch G, Derry S, Moore RA. Self-monitoringof blood glucose in type-2 diabetes: what is the evidence? Diabetes Metab Res Rev 2007; 23: 423–40.
15. Briscoe VJ, Davis SN. Hypoglycemia in Type 1 and Type 2 Diabetes: Physiology, Pathophysiology, and Management. Clinical Diabetes 2006; 24 (3): 115–21.
16. Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes. Pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 2005; 28 (12): 2948–61.
17. Shafiee G, Mohajeri-Tehrani M, Pajouhi M, Larijani B. The importance of hypoglycemia in diabetic patients. J Diabetes Metab Disord 2012; 11: 17.
18. Контур Плюс. Руководство пользователя. Байер, 2013. / Kontur Plius. Rukovodstvo pol'zovatelia. Baier, 2013. [in Russian]
19. International Organization for Standardization. International Standard EN ISO 15197:2013. In Vitro diagnostic test systems: Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. Second Edition 2013-05-15. International Organization for Standardization, 2013.
20. Caswell M, Frank J, Viggiani MT et al. Accuracy and User Performance Evaluation of a Blood Glucose Monitoring System. Diabetes Technol Ther 2015; 3: 1–7.
21. Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes 2008; 57: 3169–76.
22. Gerstein HC, Miller ME, Byington RP et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545–59.
23. Kuo CY, Hsu CT, Ho CS et al. Accuracy and precision evaluation of seven self-monitoring blood glucose systems. Diabetes Technol Ther 2011; 13: 596–600.
24. O’Kane MJ, Bunting B, Copeland M et al. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 2008; 336: 1174–7.
25. Schnell O, Hanefeld M, Monnier L. Self-Monitoring of Blood Glucose. A Prerequisite for Diabetes Management in Outcome Trials. J Diabetes Sci Technol 2014; 8 (3): 609–14.
26. Tourkmani AM, Alharbi TJ, Rsheed AMB et al. Hypoglycemia in Type 2 Diabetes Mellitus patients: A review article. Diabetes Metab Syndr 2018; 12 (5): 791–4.
27. Bailey T. et al. Journal of Diabetes Science and Technology. 2017; Vol. 11(4):736-743
________________________________________________
1. Khaled AA, Sekaran M, Ikram SI. Type 2 diabetes and vascular complications: A pathophysiologic view. Biomed Res 2010; 21 (2): 147–50.
2. IDF atlas. 8th edition.
3. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, Nathan DM, Zinman B et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983–2005). Arch Intern Med 2009; 169 (14): 1307–16.
4. Farmer A, Wade A, Goyder E et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 2007; 335: 13.
5. Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nykh sakharnym diabetom. Pod red. I.I.Dedova, M.V.Shestakovoi. 8-i vyp. M., 2017. [in Russian]
6. Blonde L, Karter AJ. Current evidence regarding the value of self monitored blood glucose testing. Am J Med 2005; 118 (Suppl 9A): 20S–6S.
7. Clar C et al. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess 2010; 14 (12): 6.
8. Maiorov A.Iu., Mel'nikova O.G., Filippov Iu.I. Voprosy samokontrolia glikemii v praktike lecheniia sakharnogo diabeta. Handbook for Practitioners Doctors. 2012; 12: 32–6. [in Russian]
9. Davidson MB, Castellanos M, Kain D et al. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med 2005; 118: 422–5.
10. Guerci B et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003; 29: 587–94.
11. Karter AJ, Ackerson LM, Darbinian JA et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med 2001; 111 (1): 1–9.
12. Polonsky WH, Fisher L, Schikman CH et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes. Results from the structured testing program study. Diabetes Care 2011; 34: 262–7.
13. Neisser K, Weber C, Wenzel H, Schneider B. Costs of self-measurement of blood glucose (SMBG) regarding morbidity and mortality in type 2 diabetes in a reality of care setting (The ROSSO study No 6). The European Association for the Study of Diabetes. Abstract Volume 42st Annual Meeting, Copenhagen, Malmoe, 2006; p. 141.
14. McGeoch G, Derry S, Moore RA. Self-monitoringof blood glucose in type-2 diabetes: what is the evidence? Diabetes Metab Res Rev 2007; 23: 423–40.
15. Briscoe VJ, Davis SN. Hypoglycemia in Type 1 and Type 2 Diabetes: Physiology, Pathophysiology, and Management. Clinical Diabetes 2006; 24 (3): 115–21.
16. Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes. Pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 2005; 28 (12): 2948–61.
17. Shafiee G, Mohajeri-Tehrani M, Pajouhi M, Larijani B. The importance of hypoglycemia in diabetic patients. J Diabetes Metab Disord 2012; 11: 17.
18. Kontur Plius. Rukovodstvo pol'zovatelia. Baier, 2013. [in Russian]
19. International Organization for Standardization. International Standard EN ISO 15197:2013. In Vitro diagnostic test systems: Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. Second Edition 2013-05-15. International Organization for Standardization, 2013.
20. Caswell M, Frank J, Viggiani MT et al. Accuracy and User Performance Evaluation of a Blood Glucose Monitoring System. Diabetes Technol Ther 2015; 3: 1–7.
21. Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes 2008; 57: 3169–76.
22. Gerstein HC, Miller ME, Byington RP et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545–59.
23. Kuo CY, Hsu CT, Ho CS et al. Accuracy and precision evaluation of seven self-monitoring blood glucose systems. Diabetes Technol Ther 2011; 13: 596–600.
24. O’Kane MJ, Bunting B, Copeland M et al. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 2008; 336: 1174–7.
25. Schnell O, Hanefeld M, Monnier L. Self-Monitoring of Blood Glucose. A Prerequisite for Diabetes Management in Outcome Trials. J Diabetes Sci Technol 2014; 8 (3): 609–14.
26. Tourkmani AM, Alharbi TJ, Rsheed AMB et al. Hypoglycemia in Type 2 Diabetes Mellitus patients: A review article. Diabetes Metab Syndr 2018; 12 (5): 791–4.
27. Bailey T. et al. Journal of Diabetes Science and Technology. 2017; Vol. 11(4):736-743
1 ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И.Евдокимова» Минздрава России. 127473, Россия, Москва, ул. Делегатская, д. 20, стр. 1;
*lena@obsudim.ru
________________________________________________
1 A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation. 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1;
*lena@obsudim.ru